212 related articles for article (PubMed ID: 15337767)
21. Binding to the naturally occurring double p53 binding site of the Mdm2 promoter alleviates the requirement for p53 C-terminal activation.
Kaku S; Iwahashi Y; Kuraishi A; Albor A; Yamagishi T; Nakaike S; Kulesz-Martin M
Nucleic Acids Res; 2001 May; 29(9):1989-93. PubMed ID: 11328884
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and NMR mapping of the interface between CREB-binding protein and ligand binding domains of nuclear receptor: beyond the LXXLL motif.
Klein FA; Atkinson RA; Potier N; Moras D; Cavarelli J
J Biol Chem; 2005 Feb; 280(7):5682-92. PubMed ID: 15542861
[TBL] [Abstract][Full Text] [Related]
23. Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53.
Golubovskaya VM; Finch R; Cance WG
J Biol Chem; 2005 Jul; 280(26):25008-21. PubMed ID: 15855171
[TBL] [Abstract][Full Text] [Related]
24. Regulatory domain of protein stability of human P51/TAP63, a P53 homologue.
Osada M; Inaba R; Shinohara H; Hagiwara M; Nakamura M; Ikawa Y
Biochem Biophys Res Commun; 2001 May; 283(5):1135-41. PubMed ID: 11355891
[TBL] [Abstract][Full Text] [Related]
25. Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.
Foulds CE; Nelson ML; Blaszczak AG; Graves BJ
Mol Cell Biol; 2004 Dec; 24(24):10954-64. PubMed ID: 15572696
[TBL] [Abstract][Full Text] [Related]
26. The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein.
Brown DR; Deb S; Muñoz RM; Subler MA; Deb SP
Mol Cell Biol; 1993 Nov; 13(11):6849-57. PubMed ID: 8413278
[TBL] [Abstract][Full Text] [Related]
27. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
28. Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53.
Zhu Q; Wani G; Wani MA; Wani AA
Cancer Res; 2001 Jan; 61(1):64-70. PubMed ID: 11196199
[TBL] [Abstract][Full Text] [Related]
29. Selective LXXLL peptides antagonize transcriptional activation by the retinoid-related orphan receptor RORgamma.
Kurebayashi S; Nakajima T; Kim SC; Chang CY; McDonnell DP; Renaud JP; Jetten AM
Biochem Biophys Res Commun; 2004 Mar; 315(4):919-27. PubMed ID: 14985100
[TBL] [Abstract][Full Text] [Related]
30. Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1.
Zhou J; Hu G; Herring BP
Mol Cell Biol; 2005 Nov; 25(22):9874-85. PubMed ID: 16260603
[TBL] [Abstract][Full Text] [Related]
31. The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/CREB-binding protein.
Liu G; Xia T; Chen X
J Biol Chem; 2003 May; 278(19):17557-65. PubMed ID: 12609999
[TBL] [Abstract][Full Text] [Related]
32. N-terminal 130 amino acids of MDM2 are sufficient to inhibit p53-mediated transcriptional activation.
Leng P; Brown DR; Shivakumar CV; Deb S; Deb SP
Oncogene; 1995 Apr; 10(7):1275-82. PubMed ID: 7731677
[TBL] [Abstract][Full Text] [Related]
33. Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP.
De Guzman RN; Liu HY; Martinez-Yamout M; Dyson HJ; Wright PE
J Mol Biol; 2000 Oct; 303(2):243-53. PubMed ID: 11023789
[TBL] [Abstract][Full Text] [Related]
34. Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain.
Razeto A; Ramakrishnan V; Litterst CM; Giller K; Griesinger C; Carlomagno T; Lakomek N; Heimburg T; Lodrini M; Pfitzner E; Becker S
J Mol Biol; 2004 Feb; 336(2):319-29. PubMed ID: 14757047
[TBL] [Abstract][Full Text] [Related]
35. Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator.
Ko L; Cardona GR; Chin WW
Proc Natl Acad Sci U S A; 2000 May; 97(11):6212-7. PubMed ID: 10823961
[TBL] [Abstract][Full Text] [Related]
36. A small domain of CBP/p300 binds diverse proteins: solution structure and functional studies.
Lin CH; Hare BJ; Wagner G; Harrison SC; Maniatis T; Fraenkel E
Mol Cell; 2001 Sep; 8(3):581-90. PubMed ID: 11583620
[TBL] [Abstract][Full Text] [Related]
37. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
38. Identification of a CK2 phosphorylation site in mdm2.
Götz C; Kartarius S; Scholtes P; Nastainczyk W; Montenarh M
Eur J Biochem; 1999 Dec; 266(2):493-501. PubMed ID: 10561590
[TBL] [Abstract][Full Text] [Related]
39. ZNF76, a novel transcriptional repressor targeting TATA-binding protein, is modulated by sumoylation.
Zheng G; Yang YC
J Biol Chem; 2004 Oct; 279(41):42410-21. PubMed ID: 15280358
[TBL] [Abstract][Full Text] [Related]
40. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1).
Schmid T; Zhou J; Köhl R; Brüne B
Biochem J; 2004 May; 380(Pt 1):289-95. PubMed ID: 14992692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
